NCT05852509 Digital Health Physical Activity Program for Older Family Care Partners of Patents With Heart Failure
| NCT ID | NCT05852509 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Denver |
| Condition | Heart Failure |
| Study Type | INTERVENTIONAL |
| Enrollment | 32 participants |
| Start Date | 2024-07-01 |
| Primary Completion | 2027-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 32 participants in total. It began in 2024-07-01 with a primary completion date of 2027-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the Aim 3 study is to conduct a pilot randomized controlled trial to assess feasibility and preliminary effects of the TPA4You intervention.
Eligibility Criteria
Inclusion Criteria: * Age greater than or equal to 50 years * Involved in caring for a household member aged 50 years or older with the New York Heart Association Class II, III or IV HF * Provide at least 8 hours/week of unpaid care for the past 3 months * Physically able to engage in structured exercise such as walking, and upper body resistance exercises * Engage in \< 30 min of moderate-intensity exercise on fewer than 3 days per week * Able to read, speak, and comprehend 5th grade English * Own a smartphone * Reachable by telephone, text messaging, and email * Have a 6x6ft space fit for physical activity in the place of residence Exclusion Criteria: * Medical or functional conditions precluding participation in the physical activity (PA) components of the intervention (e.g., inability to walk one block or climb stairs without chest pain, shortness of breath, dizziness; history of falls; or serious or unstable cardiovascular or pulmonary disease) * Cognitive impairment (Telephone Interview for Cognitive Status \[TICS\] score \< 25) * Inability to use technology * Participation in a PA intervention in the previous 6 months * Current participation in a PA or behavior change trial * Physical activity unpreparedness ('Yes' to any questions 1-4 the Physical Activity Readiness Questionnaire \[PAR-Q\]. If participants respond 'yes' to any questions 5-7, we will ask follow-up questions.)
Contact & Investigator
Dawon Baik, PhD
PRINCIPAL INVESTIGATOR
University of Colorado, Denver
Frequently Asked Questions
Who can join the NCT05852509 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05852509 currently recruiting?
Yes, NCT05852509 is actively recruiting participants. Contact the research team at dawon.baik@cuanschutz.edu for enrollment information.
Where is the NCT05852509 trial being conducted?
This trial is being conducted at Aurora, United States.
Who is sponsoring the NCT05852509 clinical trial?
NCT05852509 is sponsored by University of Colorado, Denver. The principal investigator is Dawon Baik, PhD at University of Colorado, Denver. The trial plans to enroll 32 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.